Amsterdam, December 28, 2022 – The construction of Plus Ultra Amsterdam is in full swing at the Medical Business Park Amsterdam. Medfiniti has decided to move into this new multi-tenant building. The long-term lease agreement with Kadans Science Partner was recently signed. This makes Medfiniti the first tenant of Plus Ultra Amsterdam.

Medfiniti will rent the entire sixth floor, more than 1,200 sqm, of Plus Ultra Amsterdam. Medfiniti will focus here on the further development of medical and surgical technologies and procedures and will also build in a specialized “Hemorrhoid Clinic” on location. This means that Medfiniti fits perfectly in the Health & Life Sciences target group for the Medical Business Park Amsterdam.

“With coming to Plus Ultra Amsterdam and joining the Kadans ecosystem, Medfiniti strengthens its ties with the AUMC. The Plus Ultra Amsterdam building offers Medfiniti the possibility to optimize its operations, and we look forward to adding our knowledge and experience to the Kadans ecosystem,” says Michael Goeree, CEO Medfiniti.

The new Plus Ultra Amsterdam building offers office and laboratory spaces for innovative companies, knowledge and research institutions that want to build a strong community in the Heath & Life Sciences sector together with Kadans Science Partner and the Amsterdam University Medical Center. By accommodating growing and established companies and organisations in Plus Ultra Amsterdam, meetings and collaborations are stimulated. Plus Ultra Amsterdam is part of the international network of Kadans, which connects various science parks and campuses in Europe. This way, connections are made between organisations around the AUMC, but also with organisations on other campuses.

Kadans is pleased to welcome Medfiniti to Plus Ultra Amsterdam.

The construction of Plus Ultra Amsterdam will soon reach its highest point. Completion is expected in the third quarter of 2023.

For privacy reasons YouTube needs your permission to be loaded. For more details, please see our Privacy Statement.
I Accept